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Edited by Frances ShannonAbstract The steroid/sterol sulfotransferase gene (SULT2B1)
encodes for two isozymes of which one (SULT2B1b) sulfonates
cholesterol and is selectively expressed in skin. The human
SULT2B1 gene contains neither a TATAAA nor a CCAAT mo-
tif upstream of the coding region for SULT2B1b; however, this
area is GC-rich. Of ﬁve Sp1 elements identiﬁed two had regula-
tory activity utilizing immortalized human keratinocytes: one
element is located above the ostensible transcription initiation
site, whereas the other is located within the 5 0-untranslated re-
gion of the SULT2B1b mRNA. Sp1 and Sp2 transcription fac-
tors identiﬁed by supershift analyses induced reporter gene
activity, an eﬀect markedly augmented by histone deacetylase
inhibition.
Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Enzymes that catalyze the sulfoconjugation of hormones
and neurotransmitters comprise a superfamily of cytosolic sul-
fotransferases (SULT), of which the SULT2 family, consisting
of two subfamilies (SULT2A1 and SULT2B1), is engaged in
the sulfoconjugation of steroids/sterols [19]. The gene for hu-
man SULT2B1, as a result of an alternative exon 1 and diﬀer-
ential splicing, encodes for two mRNAs, i.e., SULT2B1a and
SULT2B1b [10]. The use of exon 1A produces SULT2B1a,
whereas to produce SULT2B1b exon 1B plus a portion of exon
1A is required. SULT2B1b eﬃciently sulfonates cholesterol,Abbreviations: SULT, Sulfotransferase; nt, nucleotide; TSS, transcrip-
tion start site; UTR, untranslated region; RT, reverse transcription;
EMSA, electrophoresis mobility shift assay; HDAC, histone deacetyl-
ase; TSA, trichostatin A
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terol sulfate, quantitatively the most signiﬁcant sterol sulfate
in human plasma, has emerged as a multifaceted molecule with
noteworthy physiologic actions [26]. In the realm of keratino-
cyte development and barrier formation, cholesterol sulfate
will activate isozymes of protein kinase C [5], inhibit choles-
terol synthesis [29], induce the gene for transglutaminase I,
an essential cross-linking enzyme involved in barrier formation
[14], and regulate the gene for involucrin, a major cross-linked
protein constituent of the insoluble corniﬁed cell envelope [9].
Interestingly, cholesterol sulfate is a ligand for the retinoic
acid-related orphan nuclear receptor a (RORa), whereby it sig-
niﬁcantly increases transcriptional activity [13]; furthermore,
RORa is highly expressed in skin [25]. We previously reported
on the selective expression of the SULT2B1b isoform in hu-
man skin as well as primary cultures of normal human epider-
mal keratinocytes undergoing calcium-induced diﬀerentiation
[11], and in this communique´ present initial studies regarding
transcriptional control of expression of the SULT2B1 gene
in human keratinocytes.2. Materials and methods
2.1. Cell culture
Immortalized but highly diﬀerentiated human keratinocytes (HaCaT
cells) {originally developed by Boukamp et al. [2] and a generous gift
of Dr. Shyh-Ing Jang at the NIAMS, NIH, Bethesda, MD} were
grown in Dulbeccos modiﬁed essential medium (DMEM) supple-
mented with antibiotics and 10% fetal bovine serum unless otherwise
speciﬁed.
2.2. Isolation of human SULT2B1b 5 0-ﬂanking region and preparation
of reporter gene constructs
DNA sequence of human SULT2B1 gene obtained from the human
genome project (GenBank Accession No. AC008403) was used to pro-
duce the 5 0-ﬂanking region of the SULT2B1b isoform by employing
the Advantage Genomic PCR kit (BD Biosciences Clontech), human
genomic DNA (BD Biosciences Clontech) as template and the appro-
priate sense and antisense primers ﬂanked by Kpn1 and Xho1, respec-
tively. PCR was performed as follows: denature at 95 C for 30 s
followed by 40 cycles of denaturation at 95 C for 15 s then anneal-
ing/elongation at 68 C for 3 min. The 3389 to 27 PCR product
was gel puriﬁed (Qiagen) and sub-cloned into the pCR2.1 TA cloning
vector (Invitrogen) prior to ligation with the pGL3 luciferase reporter
gene expression vector (Promega) at Kpn1 and Xho1 restriction sites to
produce the pGL3(3389/27) construct. Nota bene: the nucleotide
(nt) numbering system employed throughout this manuscript complies
with recommended practice [4]; thus, the nt immediately upstream
of the translation initiation codon (ATG) has been denoted as 1.European Biochemical Societies.
3640 Y.C. Lee et al. / FEBS Letters 579 (2005) 3639–3645Various segments of SULT2B1b 5 0-ﬂanking region, i.e., 3189/27,
951/27, 401/27, 331/27, 212/27, 179/27, 148/27
and 125/27 were obtained by performing nested-PCR using the
pGL3(3389/27) construct as template, appropriate sense primers
and the common antisense primer (55/27) designed to be located
well downstream of the 5 0-end of the 5 0-untranslated region (UTR)
of SULT2B1b mRNA. Nested PCR was performed with pfu-Ultra
DNA polymerase (Stratagene) as follows: denature at 95 C for
1 min followed by 30 cycles of denaturation at 95 C for 30 s, anneal-
ing at 62 C for 30 s, and elongation at 72 C for appropriate durations
(1 min/kb of the expected length of each PCR product). PCR products
were subcloned into the ﬁreﬂy luciferase expression vector at Kpn1 and
Xho1 restriction sites. The additional constructs pGL3(2940/27),
pGL3(2286/27), pGL3(1740/27) and pGL3(548/27) were
generated by double digestions of the pGL3(3389/27) construct
at, respectively, Kpn1/Spe1, Kpn1/Sma1, Kpn1/AatII, and Kpn1/Mlu1
restriction sites followed by blunting and ligation.
2.3. Reverse transcription (RT) PCR analysis
Total RNA was extracted from HaCaT cells using Absolutely RNA
RT-PCRMiniprep kit (Stratagene). RT was performed using the Ther-
moScript RT-PCR system (Invitrogen). Brieﬂy, the ﬁrst cDNA strand
was synthesized at 50 C for 60 min using 1 lg of total RNA as tem-
plate and random hexamer primers. PCR was performed using 2 ll
cDNA reaction mix as template and gene-speciﬁc primer pairs using
platinum Taq DNA polymerase (Invitrogen) under the conditions of
denaturing at 94 C for 2 min, followed by 30 cycles of denaturizing
at 94 C for 30 s, annealing at 58 C for 30 s and extension at 72 C
for 30 s.
2.4. Transient transfection and reporter gene assay
HaCaT cells were seeded in 6-well plates at 2.5 · 105 cells/well 1 day
prior to transfections that were performed with a selective pGL3/
SULT2B1b upstream construct with or without Renilla luciferase plas-
mid (Promega) as indicated in ﬁgure legends. Transfections were car-
ried out using a 3-fold excess of SuperFect (Qiagen). Cells were
harvested 48 h after transfection and both ﬁreﬂy luciferase and Renilla
luciferase activities were measured (Promega). All experiments wereTable 1
Primers used for constructing, substitution mutants, RT-PCR and oligonucl
Name Sequence
Primers for site-directed mutagenesis
Sp1.2/M2(S) 5 0-CACTGCTCCTCtttGCCCTCAG
Sp1.2/M2(A) 5 0-GGAGCCACCCTGCTCTGAGGGC
Sp1.5/M5(S) 5 0-GAGAACCGGCTGGGTGCTGaaa
Sp1.5/M5(A) 5 0-GCCCAAGGGGAGtttCAGCACC
Primers for RT-PCR
RTP1(S) 5 0-CTGCCCCTCCCCTTGGGCCGGG
RTP2(S) 5 0-CTGGGTGCTGCCCCTCCCCTTG
RTP3(S) 5 0-AGAACCGGCTGGGTGCTGCCCC
RTP(S) 5 0-AGCTGGGAGAACCGGCTGGGTG
RTP5(S) 5 0-TAGCAGCTGGGAGAACCGGCTG
RTP6(S) 5 0-TTGGAGGCGTGGATAGCAG-30
RTP7(S) 5 0-TGTTGGAGGCGTGGATAGCAGC
RTP8(S) 5 0-TGTTGGAGGCGTGGATAGC-30
RTP9(S) 5 0-GCCTCTCCCCGCTGTTGG-30
RTP10(S) 5 0-AGAGCAGGGTGGCTCCCTCTGG
RTP11(A) 5 0-AGATGATCTCGATCATCCAGGT
Oligonucleotides for EMSA
WT/Sp1.2 5 0-ACTGCTCCTCCCCGCCCTCA-3
3 0-IGACGAGGAGGGGCGGGAGT-5
M2/Sp1.2 5 0-ACTGCTCCTtttCGCCCTCA-3
3 0-TGACGAGGAaaaGCGGGAGT-5
WT/Sp1.5 5 0-CGGCTGGGTGCTGCCCCTCCCC
3 0-GCCGACCCACGACGGGGAGGGG
M5/Sp1.5 5 0-CGGCTGGGTGCTGaaaCTCCCC
3 0-GCCGACCCACGACtttGAGGGG
Underlined and lower case letters indicate mutated bases. S, sense; A, antisecarried out in triplicate and repeated twice. In some experiments,
0.3 lM trichostatin A (TSA; Sigma) was added to the incubation med-
ium 12 h prior to harvesting.2.5. Site-directed mutagenesis
Transcription factor binding elements were altered using Quick
Change Site-Directed Mutagenesis (Stratagene). Brieﬂy, PCR was per-
formed using 50 ng of the pGL3(548/27) construct and 10 pmol of
sense and antisense primers (Table 1) under the conditions of denatur-
ation at 95 C for 30 s, followed by 18 cycles of denaturation at 95 C
for 30 s, annealing at a temperature determined by a formula supplied
with instructions, and extension at 68 C for 10 min. Reaction mixtures
were treated with Dpn1. PCR products were ampliﬁed with XL10-
Gold competent cells (Stratagene) and sequenced.2.6. Electrophoresis mobility shift assay (EMSA)
EMSA was carried out as follows: double stranded oligonucleotides
(Table 1) were end-labeled with 32P using [c-32P] ATP (3000 Ci/mmol,
Perkin–Elmer Life Sciences) and T4 polynucleotide kinase [22] and
column-puriﬁed with a NucTrap probe puriﬁcation column (Strata-
gene). EMSA was performed using labeled oligonucleotides (130 ·
103 cpm), HaCaT cell nuclear extract (5 lg) from Active Motive
and a commercially available kit (Promega). Samples were subjected
to electrophoresis using 6% (w/v) polyacrylamide gels in 0.5· Tris/
borate/EDTA buﬀer (0.178 M Tris/borate and 4 mM EDTA) at 4 C
for 2 h. For supershift analyses, nuclear extracts were preincubated
with 2 lg of antibody to human Sp1, Sp2, Sp3 or Sp4 (Santa Cruz
Biotechnology) for 2 h at 4 C prior to incubation with the probes
and then subjected to electrophoresis using 3.5% polyacrylamide
gels. Following electrophoresis, gels were dried and analyzed by
autoradiography.2.7. DNA sequence analysis
DNA sequence was analyzed for potential transcription factor bind-
ing using the TESS (Transcription Element Search System) web tool
(http://www.cbil.upenn.edu/cgi-bin/tess/tess?RQ=WELCOME).eotides for EMSA
Position
AGCAGGGTGGCTCC-30 (2327/197)
aaaGAGGAGCAGTG-30 (232/197)
CTCCCCTTGGGC-30 (154/121)
CAGCCGGTTCTC-30 (154/121)
CACGGAGTAG-30 (138/107)
GGCCGGGCAC-30 (145/114)
TCCCCTTGG-30 (153/124)
CTGCCCCTC-30 (160/130)
GGTGCTG-30 (164/136)
(177/159)
TGGGAG-30 (179/152)
(179/161)
(191/174)
CCTCTC-30 (212/185)
CGTGCCTG-3 0 (+212/+242)
0 (231/212)
0
0 (231/212)
0
TTGGGCCG-3 0 (148/119)
AACCCGGC-5 0
TTGGGCCG-3 0 (148/119)
AACCCGGC-5 0
nse; WT, wild type.
Fig. 1. Various constructs (1.5 lg) of the 5 0-ﬂanking region fused to the ﬁreﬂy luciferase reporter gene vector were co-transfected along with Renilla
luciferase expression vector (0.2 lg) into HaCaT cells. Fireﬂy luciferase activity was normalized to Renilla luciferase activity and the relative
luciferase activities (RLA) are presented as fold-increase over the promoterless pGL3 basic vector. The length of each 5 0-ﬂanking segment, which is
relative to the translation initiation ATG codon (A is +1), is indicated to the left of each proportional line. The location of regulatory Sp1 sites is
indicated with closed circles. Horizontal column lengths represent the average of multiple replicates and error bars are indicated.
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3.1. SULT2B1promoter activity upstream of exon 1B
A 3363 base pair (bp) fragment of the human SULT2B1
gene upstream of exon 1B and spanning nucleotides 3389
to 27 (relative to the ATG initiation codon) was cloned.
When this sequence was examined for promoter activity by
deletion analysis, a bimodal activity pattern was produced with
a proximal peak in activity around nt 401 and a second peak
near nt 3189 (data not presented). For our initial foray into
regulation of this gene, we opted to concentrate on the more
downstream or proximal promoter region, and a deletion anal-
ysis involving nucleotides 548 to 27 is depicted in Fig. 1.Fig. 2. DNA sequence of the proximal promoter region of the human SULT
Potential transcription factor binding sites as revealed using the TESS Web T
sequential numbering following a period).3.2. Analysis of the proximal promoter region of human
SULT2B1b
The DNA sequence of the SULT2B1b 5 0-ﬂanking region
extending from 1 to 548 (relative to ATG) contains multi-
ple potential transcription factor binding sites (Fig. 2), includ-
ing AP-2(1), Ets-1(1), Ets-2(1), Pit-1a(4), NF-1(1), AP-1(1),
AP-4(1) and Sp1(5) where numbers in parentheses denote the
number of potential sites. Mutational analysis revealed that
when these sites were individually altered and examined by
transfection, either no eﬀect on promoter activity (AP-1, AP-
4 and NF-1) or modest decreases in activity ranging from
20% to 40% were noted (data not presented). Regarding
the ﬁve Sp1 sites, mutation of three sites (Sp1.1, Sp1.3 and2B1 gene (+1 indicates the A in the ATG translation initiation codon).
ool are underlined and labeled (multiple similar motifs are indicated by
Fig. 3. RT-PCR products obtained using various sense primers
located downstream and upstream of the purported TSS as previously
reported [10]. Lanes 1–10 show results obtained using the correspond-
ingly numbered sense primers RTP1, RTP2, RTP3, RTP4, RTP5,
RTP6, RTP7, RTP8, RTP9 and RTP10 and a common antisense
primer (RTP11) located in exon 2 (cf. Table 1).
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sented), whereas mutation of Sp1.2 and Sp1.5 suggested regu-
latory activity, and altering the two sites concurrently led to
complete loss in activity (vide infra). Combinations of either
the Sp1.2 or Sp1.5 site with other Sp1 sites, as well as combi-
nations of either of these Sp1 sites with other potential tran-
scription factor binding sites noted above produced
essentially the same result as mutating the sites individually
(data not presented). It was noted that the Sp1.2 and Sp1.5
mutational results were consistent with results of the deletion
analyses (cf. Fig. 1).
3.3. Transcription start site (TSS) of human SULT2B1b gene
In order to determine the relationship of regulatory Sp1.2
and Sp1.5 elements to transcription initiation, an examination
of the TSS for SULT2B1b was undertaken by RT-PCR, a pro-
cedure that employed an antisense primer located in exon 2,
and various overlapping sense primers ranging from nt 107Fig. 4. EMSA involving probes containing either Sp1.2 (A and C) or Sp1.5
labeled probe; lane 2, labeled probe and 100-fold excess of unlabeled probe;
small arrow denote upshifted bands. Panels C/D: lane 1, no antibody; lane 2, a
antibody to Sp4. Open arrowhead denotes band of Sp1/Sp2 protein–probe co
bands with antibodies to Sp1 and Sp2, respectively.to nt 212 (Table 1). All sense primers up to primer 8 yielded
PCR products, indicating that these sequences were part of
SULT2B1b mRNA, whereas the 9th and 10th sense primers
failed to yield PCR products indicating that these sequences
were not part of SULT2B1b mRNA (Fig. 3). Based on the
RT-PCR results, it was concluded the 5 0-end of the 5 0-UTR
of SULT2B1b mRNA extends beyond nt 161, perhaps to
nt-174 (cf. Fig. 2).
3.4. Electrophoresis mobility shift analysis
EMSA examination revealed that probes encompassing
either the Sp1.2 or Sp1.5 site produced upshifted bands using
HaCaT cell nuclear extracts (Fig. 4). The probe containing
the Sp1.2 site produced 3 upshifted bands (Fig. 4A, lane 1),
whereas the probe containing the Sp1.5 site produced 2 upshif-
ted bands (Fig. 4B, lane 1). Speciﬁcity was ascertained when
upshifted bands disappeared when radio-labeled probes were
incubated with an excess of unlabeled counterparts (Fig. 4A/
B, lane 2). When the Sp1 site within each probe was mutated,
however, only the topmost upshifted bands disappeared (Fig.
4A/B, lane 3). That the topmost upshifted band represented
both Sp1 and Sp2 protein was indicated by supershift analyses,
i.e., antibody to either Sp1 or Sp2 produced supershifted bands
(Fig. 4C/D, lanes 2,3). On the other hand, antibodies to Sp3
and Sp4 produced no supershifted bands (Fig. 4C/D, lanes 4
and 5).
3.5. Transfection of HaCaT cells with Sp1 and Sp2 expression
vectors
The potential role of Sp1 and Sp2 on SULT2B1b proximal
promoter activity was explored by co-transfecting HaCaT cells
with Sp1 or Sp2 expression vectors singly or in combination
along with the 548/27 reporter gene construct. An increase
in promoter activity with both Sp1 and Sp2 was consistently
noted with Sp1 being more potent than Sp2, although a subop-
timal combination of Sp1 and Sp2 produced a synergistic re-(B and D) motifs and HaCaT cell nuclear extracts. Panels A/B: lane 1,
lane 3, labeled mutant probe. Open arrowhead, closed arrowhead and
ntibody to Sp1; lane 3, antibody to Sp2; lane 4, antibody to Sp3; lane 5,
mplex, whereas closed arrowhead and small arrow denote supershifted
Fig. 5. Promoter activity of SULT2B1 gene in response to cotransfection of HaCaT cells with Sp1 and Sp2 expression vectors. Cells were
cotransfected with 1 lg of various forms of the proximal promoter construct pGL3(548/27), i.e., unmutated (WT), mutated Sp1.2 (M2), mutated
Sp1.5 (M5) and combination of mutated Sp1.2 and Sp1.5 (M2/M5) along with 1.5 lg pRSVSp1 or 1.5 lg pCMVSp2 expression vectors (1 lg in
combination experiments). M2 and M5 were obtained by site-directed mutagenesis using the WT pGL3(548/27) construct as a template and the
site-directed mutagenesis primers listed in Table 1. The double mutant construct (M2/M5) was obtained using the M2 mutant construct as a template
and M5 site-directed mutagenesis primer. Luciferase activity (LU) was determined 48 h after transfection and normalized to protein concentration.
Basic pRSV vector was added to equalize the amount of DNA used. Column heights represent the average of multiple replicates, and error bars are
indicated.
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crease in promoter activity, whereas mutation of Sp1.5 pro-
duced a more signiﬁcant decrease in promoter activity;
however, when Sp1.2 and Sp1.5 were mutated simultaneously,
promoter activity was lost (Fig. 5). Co-transfection of Sp1 and/
or Sp2 with mutation of the Sp1.2 site yielded similar results as
with wild type. In contrast, co-transfection of Sp1 and/or Sp2
with mutation of the Sp1.5 site resulted in a signiﬁcant reduc-
tion in promoter activity compared to wild type (Fig. 5). When
TSA, the histone deacetylase (HDAC) inhibtor, was added to
the HaCaT cell culture medium, a striking augmentation in re-
porter gene activity occurred (Fig. 6). Furthermore, TSA plus
Sp2 increased promoter activity 60%, whereas TSA plus Sp1
increased promoter activity 4-fold compared to TSA aloneFig. 6. The experiments described in Fig. 5 were repeated in the presence
determination of luciferase activity. For comparative purposes, data in Fig.
Column heights represent the average of multiple replicates, and error bars(Fig. 6). The presence of TSA with a mutated Sp1.2 site yielded
a paradoxical increase in promoter activity over wild type in
contrast to TSA with the mutated Sp1.5 site, which resulted
in a clear decrease in promoter activity (Fig. 6). As in the case
when TSA was not present, mutation of the two Sp1 sites
simultaneously resulted in a complete loss of promoter activity
even in the presence of TSA (Fig. 6).4. Discussion
The gene for human SULT2B1 contains neither a canonical
TATAAA nor a CCAAT motif in the upstream region ﬂank-
ing exon 1B that encodes for the SULT2B1b isoform; nor isof 0.3 lM TSA, which was added 12 h prior to harvesting cells for
5 are included here using the same scale used for the (+)TSA results.
are indicated.
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many TATA-lacking as well as TATA-containing promoters
[24]. To establish the TSS for SULT2B1 expression of the
SULT2B1b isoform, a variety of methods were utilized, includ-
ing primer-extension, RNase protection and the RNA ligase-
mediated rapid ampliﬁcation of cDNA ends (RACE). The
sum result of these studies suggested the existence of multiple
start sites. While some TATA-less promoters retain the ability
to direct transcription initiation from a speciﬁc nt, others ap-
pear to direct transcription initiation from multiple sites [24].
Nevertheless, because of the variability in potential start sites,
RT-PCR was employed to determine at least a minimal length
for the dominant SULT2B1b mRNA 5 0-UTR (assuming mul-
tiple species exist). These results suggested the 5 0-end of the
SULT2B1b mRNA extends beyond nt 161 and may extend
to nt 174 upstream of the ATG initiation codon, a location
creating a 5 0-UTR length signiﬁcantly longer than any size
determined by the other methods employed. Placing the 5 0-
end at nt 174 is more in keeping with the original report of
the 5 0-end of the SULT2B1b mRNA being located at nt
149 upstream of the start of translation as determined by
the standard 5 0-RACE procedure [10]. While we do not have
precise knowledge of the TSS for the SULT2B1b isoform, nev-
ertheless, locating the TSS between nt 161 and nt 174 up-
stream of the translation initiation codon seems reasonable.
Many TATA-less promoters are characterized by the pres-
ence of multiple GC boxes, which bind the Sp1 transcription
activator forming a central role in the assembly of the tran-
scription complex of these promoters [21]. Regulation of the
SULT2B1 gene expressing the SULT2B1b isoform is at least
partly under the inﬂuence of the Sp1 family of transcription
factors, i.e., the area upstream of the coding region of
SULT2B1b contains multiple GC/GT boxes, and mutational
analyses indicated involvement of GC/GT boxes located be-
tween nt 215 and nt 221 (Sp1.2) and between nt 127
and nt 136 (Sp1.5) in transcriptional regulation. Further-
more, progressive shortening of the 5 0-ﬂanking region yielded
results entirely consistent with the mutational experiments.
Locating the TSS at nt 161 places the two regulatory Sp1 ele-
ments above and below the TSS, i.e., Sp1.2 is 23 nt upstream of
the TSS, whereas Sp1.5 is 47 nt downstream of the TSS placing
it within the 5 0-UTR, and transcriptional regulation within the
5 0-UTR is known [1,28]. Promoter activity within exon 1 rep-
resents a positive internal regulatory sequence [17], an eﬀect
that is commonly due to the presence of functional Sp1 bind-
ing elements [17,8,18,23,3].
Support for the Sp1 family regulating the human SULT2B1
gene was also obtained when nuclear extracts from HaCaT
cells expressing SULT2B1b were found to contain proteins
that bound to probes containing Sp1 sites as well as to the
presence of Sp1 and Sp2 proteins in those nuclear extracts.
Additionally, co-transfection of HaCaT cells with Sp1 and/or
Sp2 expression vectors produced dose-dependent increases in
promoter activity, although transcriptional activation by Sp2
was less potent than that produced by Sp1. Interestingly, co-
expression of Sp1 and Sp2 in suboptimal amounts produced
a synergistic eﬀect. Use of a HDAC inhibitor resulted in a dra-
matic augmentation in reporter gene activity induced by Sp1,
an eﬀect not seen with Sp2. Furthermore, the synergism pro-
duced by Sp1 and Sp2 in the absence of TSA treatment, was
not demonstrable in the presence of TSA, i.e., the level of tran-
scriptional activation with Sp1 and Sp2 in the presence of TSAwas no greater than that which occurred with Sp1 alone plus
TSA. It was thus concluded that, whereas Sp1 functions as a
transactivator of the SULT2B1 gene regulating expression of
the SULT2B1b isoform, the role of Sp2 is less clear despite
its apparent ability to enhance the eﬀect of Sp1 in experiments
where HDAC inhibition was not employed. Stimulation of
promoter activity seen with TSA alone in the absence of Sp1
co-transfection might have been due in part to the presence
of endogenous Sp1 in HaCaT cells. That Sp1-stimulated
SULT2B1b promoter activity by inducing histone acetylation
was suggested when the eﬀect of HDAC inhibition was lost
with mutation of the regulatory Sp1-binding sites. Addition-
ally, it is possible that TSA activation of promoter activity is
mediated by stabilizing acetylation of Sp1 itself, which in turn
could recruit other factors to the active site [12].
A major hurdle in activating transcription is the presence of
a nucleosomal barrier that limits access of the transcription
machinery to DNA templates [20]. Mechanisms exist, however,
that enable cells to relieve nucleosomal repression such as
modiﬁcation of chromatin components, particularly histone
acetylation [15], which promotes gene transcription by making
promoter sequences accessible to transcription factors [7],
whereas the association with HDAC contributes to the sup-
pressive activity of several transcription factors [15]. Addition-
ally, acetylation of nonhistone proteins, e.g., transcription
factors as noted previously for Sp1, also occurs, which can
have regulatory implications [15]. Activation of a given pro-
moter requires multiple transcription factors that bind co-
operatively to their cognate sites or possibly act synergistically
by other mechanisms. A unique feature of Sp1 as a transcrip-
tion factor is its synergistic activation and interaction with
other transcription factors [16]. In this regard, there were
two unidentiﬁed proteins, in addition to the Sp1 and Sp2 pro-
teins that speciﬁcally bound to probes containing the Sp1 mo-
tifs, and an eﬀort is currently under way to identify these
proteins. It is known that Sp1 and related family members
are not the only proteins to recognize GC/GT boxes. Several
other zinc-ﬁnger proteins have been found to have a binding
speciﬁcity similar to Sp1 [27]. Of course, this initial report on
transcriptional regulation of the SULT2B1 gene represents
only the tip of the iceberg.References
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